Since new information is coming out about the safety of frequently used medications, pharmacists need to review this information with regard to previously published information and discuss how to apply the new information to the current patient population.
The CPE discussion is available at:
The disclosure policies of the SIUE School of Pharmacy Office of Continuing Professional Education requires all persons in a position to control content to disclose any relevant financial relationships with commercial interests. If a conflict is identified, the Office of Professional Continuing Education will initiate a process for resolving the conflict. The existence of relationships does not necessarily imply bias or lessen the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The persons required to disclose conflicts include all course faculty, the SIUE CPE administrator, all activity planners and all reviewers. The relevant commercial financial relationships or affiliations must have occured over the past 12 months.
The participant must provide the correct NABP ePID number/DOB combination in their electronic profile. All CPE evaluations must be completed within 60 days of completing the activity. It is the participant's responsibility to check that their credit records are correct within the 60 day period after completion of the activity. Log in to CPE Monitor at www.mycpemonitor.net to view a list of all ACPE-accredited activities you have taken. Any discrepancies must be resolved with the CPE Provider directly and in a timely manner.
Requirements for CE Credit
Participants must complete the exercise, the post-test questions and the online evaluation to receive credit.
There are low palliative care referrals among hematologic malignancy patients. The goal of this CPE is to raise awareness among pharmacists of the unmet palliative care needs of hematologic malignancies.
Course Link: https://youtu.be/rgSLFqGhnkk
- Contrast the palliative care needs between hematologic and solid malignancies
- Describe the significant symptom burden experienced by patients with hematologic malignancies.
- Identify the strengths and weaknesses of the Hochman et al 2017 study comparing palliative care needs of patients with hematologic and solid malignancies
Eva E Coulson, B.S., Pharm.D.
Brief Bio : Eva E. Carlson earned her Pharm.D. degree degree from Texas Tech University Health Sciences Center School of Pharmacy.
Disclosure : Eva E. Coulson has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.
Release Date: Nov 27, 2017
Credit Expiration Date: Nov 27, 2020